Edition:
United States

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

688.55INR
6:24am EDT
Change (% chg)

Rs-20.55 (-2.90%)
Prev Close
Rs709.10
Open
Rs710.85
Day's High
Rs710.85
Day's Low
Rs680.00
Volume
383,104
Avg. Vol
652,494
52-wk High
Rs878.00
52-wk Low
Rs285.00

Latest Key Developments (Source: Significant Developments)

India's Jubilant Life Sciences March-qtr profit surges
Tuesday, 23 May 2017 07:58am EDT 

May 23 (Reuters) - Jubilant Life Sciences Ltd ::Recommended dividend of 3 rupees per share.March quarter consol net profit 1.49 billion rupees.March quarter consol total revenue from operations 16.41 billion rupees.Net profit in March quarter last year was 108.6 million rupees as per ind-as; total revenue from operations was 15.16 billion rupees.  Full Article

Jubilant Life Sciences receives ANDA approval for Amlodipine, Olmesartan Medoxomil tablets
Wednesday, 17 May 2017 02:54am EDT 

May 17 (Reuters) - Jubilant Life Sciences Ltd :Says Jubilant receives ANDA approval for Amlodipine and Olmesartan Medoxomil tablets.Says drugs used for the treatment of hypertension.  Full Article

India's Jubilant Life Sciences to buy Triad Isotopes' radiopharmacy business
Thursday, 4 May 2017 10:34pm EDT 

May 5 (Reuters) - Jubilant Life Sciences Ltd :Says Jubilant to acquire radiopharmacy business of Triad Isotopes.Deal to be funded via JPL’s internal accruals and is likely to be earnings accretive in first full year of operations.Says unit jubilant pharma signed an asset purchase agreement with Triad Isotopes Inc. and Isotope Holdings.  Full Article

Jubilant Life Sciences gets ANDA approval for olmesartan medoxomil tablets
Tuesday, 25 Apr 2017 01:03am EDT 

April 25 (Reuters) - Jubilant Life Sciences Ltd :Says Jubilant Life Sciences receives ANDA approval for olmesartan medoxomil tablets.Says tablets used for treatment of hypertension.  Full Article

Jubilant Life Sciences' generic drug gets FDA nod for osteoarthritis, rheumatoid arthritis
Thursday, 6 Apr 2017 01:49am EDT 

Jubilant Life Sciences Ltd : Says Jubilant Life Sciences receives ANDA approval for Celecoxib capsules .Says drug is used for the treatment of osteoarthritis and rheumatoid arthritis.  Full Article

Jubilant Life Sciences' generic drug for fungal infection gets FDA nod
Monday, 27 Feb 2017 02:42am EST 

Jubilant Life Sciences Ltd : Says Jubilant Life Sciences receives ANDA approval for itraconazole capsules .Says itraconazole capsules is the generic version of Sporanox which is used for the treatment of fungal infections.  Full Article

Jubilant Life Sciences gets ANDA approval for Darifenacin ER tablets
Thursday, 13 Oct 2016 02:11am EDT 

Jubilant Life Sciences Ltd :Says Jubilant Life Sciences receives ANDA approval for Darifenacin ER tablets.  Full Article

Jubilant Life Sciences gets Australian approval for Lyophilized kit
Tuesday, 4 Oct 2016 11:46pm EDT 

Jubilant Life Sciences Ltd :Says Jubilant receives Australian approval for Lyophilized kit for the preparation of Tc 99m MAA injection.  Full Article

Jubilant Life Sciences says unit to issue high yield bonds outside India
Friday, 23 Sep 2016 12:21am EDT 

Jubilant Life Sciences Ltd : Approved the proposal to launch a benchmark offering of unsecured high yield bonds outside India by JPL .The notes are proposed to be listed on the Singapore Exchange Securities Trading Limited.  Full Article

Jubilant Life Sciences gets ANDA approval for felodipine ER tablets
Wednesday, 24 Aug 2016 10:35pm EDT 

Jubilant Life Sciences Ltd : Jubilant Life Sciences receives ANDA approval for Felodipine ER tablets .  Full Article

More From Around the Web

BRIEF-Jubilant Life Sciences increases price up to 15 pct for its vitamin B3

* Says price increase of up to 15% for its vitamin B3 (Niacin & Niacinamide) with immediate effect, for non-contract customers Source text for Eikon: Further company coverage: